Intercure Ltd Revenue per Employee (INCR), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Intercure Ltd   (NASDAQ: INCR)
 

Intercure Ltd 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 318.38% in the fourth quarter 2025, year on year to cumulative value of $270 million, Intercure Ltd 's revenue per employee grew on a trailing twelve months basis to $ 600,444, this is below the company average.
Within the Healthcare sector Employees of 158 other companies have achieved higher revenue per employee. While Intercure Ltd 's total ranking has deteriorated compared to the previous quarter from 0 to 1536. Intercure Ltd has 450 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

INCR Revenue per Employee (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Revenue Change 318.38 % - - - -33.18 %
Sales per Employee (TTM) $ 600,444 143,515 143,515 143,515 143,515
INCR's Total Ranking # 1536 # 0 # # #
Seq. Revenue Change - - - - -

INCR Company Profile >> Back to INCR Efficiency Comparisons >> Compare INCR Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 106
Healthcare Sector # 159
Overall Market # 1536

Revenue per Employee Statistics
High Average Low
$ 863,742 $ 654,648 $ 488,171
(Dec 31 2022)   (Dec 31 2021)



Financial Statements
Intercure Ltd 's Revenue MRQ $ 270 Millions Visit INCR's Income Statement
Intercure Ltd 's Revenues TTM $ 270 Millions Visit INCR's aggregate revenue growth
What are INCR's Sales? Visit INCR's Sales by Segment




Other Ratios
Intercure Ltd 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
INCR's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for INCR's Competitors
Revenue per Employee for INCR's Suppliers
Revenue per Employee for INCR's Customers

You may also want to know
INCR's Sales Growth Rates INCR's Pe Price to earnings ratio INCR's Receivables Turnover Ratio INCR's Stock Quote
INCR's Net Income Growth Rates INCR's Ps Price to Sales ratio INCR's Sales per Employee INCR's Asset Turnover Ratio
INCR's Net Margin INCR's Pb Price to Book ratio INCR's Financial Strength Ratios INCR's Dividend Payout Ratio
Date modified: 2026-07-07T11:48:09+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2025Number of Employees Dec 31 2025
Madrigal Pharmaceuticals Inc   1,047,434.97 $ 958.403  Million 915 
Corcept Therapeutics Inc  1,043,023.29 $ 761.407  Million 730 
Integrated Biopharma Inc  1,021,360.00 $ 51.068  Million 50 
Biomarin Pharmaceutical Inc  1,000,078.55 $ 3,221.253  Million 3,221 
Coya Therapeutics Inc   993,219.13 $ 7.946  Million 8 
Assembly Biosciences Inc   990,452.05 $ 72.303  Million 73 
Travere Therapeutics Inc   987,380.28 $ 490.728  Million 497 
Hims and Hers Health Inc   961,252.25 $ 2,347.378  Million 2,442 
Sanara Medtech Inc   949,972.34 $ 102.597  Million 108 
Cue Biopharma Inc   947,103.45 $ 27.466  Million 29 
Lifevantage Corp  934,533.63 $ 208.401  Million 223 
Regeneron Pharmaceuticals Inc   930,752.76 $ 14,342.900  Million 15,410 
Ani Pharmaceuticals Inc  910,686.60 $ 883.366  Million 970 
Keenova Therapeutics Plc  906,562.50 $ 1,450.500  Million 1,600 
Scilex Holding Company  889,794.12 $ 30.253  Million 34 
Evolus Inc   889,541.92 $ 297.107  Million 334 
Day One Biopharmaceuticals Inc   888,662.92 $ 158.182  Million 178 
Xtant Medical Holdings Inc   882,602.65 $ 133.273  Million 151 
Nektar Therapeutics  876,698.41 $ 55.232  Million 63 
Pacira Biosciences inc   876,249.70 $ 726.411  Million 829 
Merck and Co Inc   866,813.33 $ 65,011.000  Million 75,000 
Carlisle Companies Incorporated  850,830.51 $ 5,019.900  Million 5,900 
Alphatec Holdings Inc   836,679.08 $ 763.888  Million 913 
Pfizer Inc  834,386.67 $ 62,579.000  Million 75,000 
Ardelyx inc   832,965.24 $ 407.320  Million 489 
Emergent Biosolutions Inc   825,444.44 $ 742.900  Million 900 
Monte Rosa Therapeutics Inc   824,480.00 $ 123.672  Million 150 
Fortress Biotech Inc   811,051.28 $ 63.262  Million 78 
Sanuwave Health Inc   800,927.27 $ 44.051  Million 55 
Adma Biologics Inc   785,336.94 $ 508.113  Million 647 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.